| Stabilization of amorphous paracetamol based systems using traditional and novel strategies LM Martínez, M Videa, GA López-Silva, CA de Los Reyes, J Cruz-Angeles, ... International journal of pharmaceutics 477 (1-2), 294-305, 2014 | 55 | 2014 |
| Co-amorphous simvastatin-nifedipine with enhanced solubility for possible use in combination therapy of hypertension and hypercholesterolemia C Martínez-Jiménez, J Cruz-Angeles, M Videa, LM Martínez Molecules 23 (9), 2161, 2018 | 42 | 2018 |
| Application of ATR‐FTIR spectroscopy to the study of thermally induced changes in secondary structure of protein molecules in solid state J Cruz‐Angeles, LM Martínez, M Videa Biopolymers 103 (10), 574-584, 2015 | 29 | 2015 |
| Highly soluble glimepiride and irbesartan co-amorphous formulation with potential application in combination therapy J Cruz-Angeles, M Videa, LM Martínez AAPS PharmSciTech 20, 1-12, 2019 | 28 | 2019 |
| Mechanical activation by ball milling as a strategy to prepare highly soluble pharmaceutical formulations in the form of co-amorphous, co-crystals, or polymorphs LM Martínez, J Cruz-Angeles, M Vázquez-Dávila, E Martínez, P Cabada, ... Pharmaceutics 14 (10), 2003, 2022 | 15 | 2022 |
| Controlled water content for evaluation of denaturation temperature of freeze-dried enzymes LM Martínez, M Videa, J Cruz-Angeles, SL Rodríguez Thermochimica acta 638, 52-57, 2016 | 8 | 2016 |
| Development and Validation of a Rapid Analytical Method for the Simultaneous Quantification of Metabolic Syndrome Drugs by HPLC-DAD Chromatography J Cruz-Angeles, LM Martínez, M Videa, J Rodríguez-Rodríguez, ... Scientia Pharmaceutica 89 (1), 8, 2021 | 5 | 2021 |
| Effect of Basic Amino Acids on Folic Acid Solubility K Pérez-Carreón, LM Martínez, M Videa, J Cruz-Angeles, J Gómez, ... Pharmaceutics 15 (11), 2544, 2023 | | 2023 |
| DESARROLLO DE UN NUEVO SISTEMA CO-AMORFO IRBESARTÁN–GLIMEPIRIDA PARA EL TRATAMIENTO DEL SÍNDROME METABÓLICO J Cruz-Angeles Diseño y Síntesis de derivados esteroidales de valina como inhibidores de la …, 0 | | |
| Nano co-amorphous solid dispersion of simvastatin–nifedipine for the treatment of cardiovascular diseases Main Area: Nanobiotechnology and Nanomedicine J Cruz-Angeles, A Reyes, M Videa, LM Martínez Carbon-MEMS, 0 | | |
| New Co-amorphous Drug Formulation with Enhanced Solubility Intended to be used as a Model for Combination Therapy for High Index Diseases CM Jiménez Fisicoquímica (FISQ ISSN 2448-914X, 6, 0 | | |
Luz María MartínezTecnológico de MonterreyDirección de correo verificada de tec.mx
